FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)

View source ↗

Summary

The FDA approved a supplemental application for POMALYST (pomalidomide) by Celgene Corporation, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

SUPPL AP for POMALYST (POMALIDOMIDE)